System Integration

In drug development, project delays can equal meaningful increases in costs that can impact your profitability and the viability of bringing your drug to market.⁵ Our goal is to help you anticipate obstacles, mitigate risks and solve for operational challenges, so your combination product meets timelines and performs under real-life conditions. BD can help augment your combination development capabilities and support efficiency through:

• Reliable performance during fill, finish and assembly to minimize operational expenses and waste
• Reproducible performance across millions of units. From 2010 through 2018, BD has received less than 3 reported complaints per million associated with system integration for BD Physioject™ disposable autoinjector annually.² At BD, we take complaints seriously but also as an opportunity to understand how that product is performing in a final combination product or as a subsystem with other systems. This experience strengthens our expertise to support and help de-risk future combination product development.

Launching a combination product can come with many challenges.⁵ As a global partner with deep expertise in drug delivery solutions and drug device combination products, BD can help you bring your drug to market smoothly and efficiently by¹:

• Helping de-risk development activities
• Providing robust system data on specific combination products to inform your development decisions
• Supporting you in a complex regulatory environment for registration and regulatory filings
   

The impact of our extensive industry experience:

• More than 11 billion BD glass barrels and stoppers sold from 2014 to 2018¹
• More than 51 million BD autoinjectors sold from 2014 to 2018¹